Investing
Sales of short-term available-for-sale investments
Humana Sales of short-term available-for-sale investments decreased by 72.6% to $395.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 24.3%, from $522.00M to $395.00M. Over 4 years (FY 2021 to FY 2025), Sales of short-term available-for-sale investments shows an upward trend with a 16.4% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
First reportedQ1 2013
Last reportedQ1 2026Apr 29, 2026
Metric ID:
adi_sales_of_short_term_investmentsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $468.00M | $499.00M | $627.00M | $1.29B | $69.00M | $616.00M | $455.00M | $50.00M | $761.00M | $4.00M | $2.98B | $391.00M | $108.00M | $1.26B | $1.62B | $522.00M | $721.00M | $3.82B | $1.44B | $395.00M |
| QoQ Change | — | +6.6% | +25.7% | +106.4% | -94.7% | +792.8% | -26.1% | -89.0% | >999% | -99.5% | >999% | -86.9% | -72.4% | >999% | +28.5% | -67.7% | +38.1% | +430.2% | -62.2% | -72.6% |
| YoY Change | — | — | — | — | -85.3% | +23.4% | -27.4% | -96.1% | >999% | -99.4% | +554.9% | +682.0% | -85.8% | >999% | -45.7% | +33.5% | +567.6% | +203.7% | -10.8% | -24.3% |
Range$4.00M – $3.82B
CAGR-3.5%
Avg YoY Growth>999%
Median YoY Growth+6.3%
Current Streak2 quarters decline
Sales of short-term available-for-sale investments at Other Companies
Frequently Asked Questions
- What is Humana's sales of short-term available-for-sale investments?
- Humana (HUM) reported sales of short-term available-for-sale investments of $395.00M in Q1 2026.
- How has Humana's sales of short-term available-for-sale investments changed year-over-year?
- Humana's sales of short-term available-for-sale investments decreased by 24.3% year-over-year, from $522.00M to $395.00M.
- What is the long-term trend for Humana's sales of short-term available-for-sale investments?
- Over 4 years (2021 to 2025), Humana's sales of short-term available-for-sale investments has grown at a 16.4% compound annual growth rate (CAGR), from $3.55B to $6.51B.